16
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Lung carcinomas in rats after low level cadmium inhalationFootnote

, , , &
Pages 41-51 | Received 30 Sep 1983, Published online: 19 Sep 2008
 

Three groups of 40 male Wistar rats were continuously exposed to CdCl2 aerosols at 3 concentrations: 12.5, 25 and 50 μg/m3 for 18 months. Forty‐one rats kept in fresh air served as controls. Thirteen months after termination of the exposure, the surviving animals were sacrificed. Body weights and mortality were not significantly different between the four groups. Primary lung carcinomas, i.e. epidermoid carcinomas, adenocarcinomas, combined epidermoid and adenocarcinomas, and mucoepidermoid carcinomas were found in 71.4% (50 μg/m3 group), 52.6% (25 μg/m3 group) and 15.4% (12.5 μg/m3 group) of the animals respectively. In addition, metastases in regional lymph nodes and the kidneys and invasion into regional lymph nodes and the heart were observed. Lung adenomas and nodular hyperplasia developed in several rats of the exposed groups. No primary lung tumors were found in the control group. These studies revealed a dose dependent incidence of primary lung carcinomas after inhalation of CdCl2 aerosols in rats. Even a concentration of 12.5 μg/m3—well below present TLV values—led to a significant lung carcinoma rate.

Notes

Presented at the Workshop on Carconogenic and/or Mutagenic Metal Compounds, Geneva, September 12–14, 1983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.